Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Delayed-release Multi Matrix System (MMX) mesalazine in ulcerative colitis: a viewpoint by Cosimo Prantera.

× No keyword cloud information.

4 in total

1. Once-daily, high-concentration MMX mesalamine in active ulcerative colitis.

Authors: Michael A Kamm; William J Sandborn; Miguel Gassull; Stefan Schreiber; Lechoslaw Jackowski; Todd Butler; Andrew Lyne; David Stephenson; Mary Palmen; Raymond E Joseph
Journal: Gastroenterology Date: 2006-10-12 Impact factor: 22.682

2. A new oral delivery system for 5-ASA: preliminary clinical findings for MMx.

Authors: Cosimo Prantera; Angelo Viscido; Livia Biancone; Antonio Francavilla; Lucio Giglio; Massimo Campieri
Journal: Inflamm Bowel Dis Date: 2005-05 Impact factor: 5.325

3. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.

Authors: G D'Haens; D Hommes; L Engels; F Baert; L van der Waaij; P Connor; J Ramage; O Dewit; M Palmen; D Stephenson; R Joseph
Journal: Aliment Pharmacol Ther Date: 2006-10-01 Impact factor: 8.171

4. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.

Authors: Gary R Lichtenstein; Michael A Kamm; Prabhakar Boddu; Natalya Gubergrits; Andrew Lyne; Todd Butler; Kirstin Lees; Raymond E Joseph; William J Sandborn
Journal: Clin Gastroenterol Hepatol Date: 2007-01 Impact factor: 11.382

4 in total